CNS Pharmaceuticals, Inc. ( CNSP) - Key Metrics
CNSP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.38 | -$0.52 | -$0.52 |
| 2026Q1 | $0 | -$7.30 | -$6.87 | -$6.88 |
| 2025Q4 | $0 | -$13.43 | -$6.88 | -$6.92 |
| 2025Q3 | $0 | -$5.76 | -$3.89 | -$3.89 |
| 2025Q2 | $0 | -$6.42 | -$14.44 | -$14.44 |
CNSP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.14 |
| 2026Q1 | 0% | -0.08 |
| 2025Q4 | 0% | -0.13 |
| 2025Q3 | 0% | -0.39 |
| 2025Q2 | 0% | -0.39 |
CNSP
Price: $5.34
52 week price:
Earnings Per Share: -15.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 89600
Market Capitalization: 7.8 million